Long-term treatment with natalizumab in paediatric multiple sclerosis (MS)

被引：0
|
作者：
Talab, R. [1 ]
Talabova, M. [2 ]
机构：
[1] Charles Univ Prague, Dept Neurol, Fac Med Plzen, Prague, Czech Republic
[2] Univ Hosp Hradec Kralove, MS Ctr, Hradec Kralove, Czech Republic
来源：
MULTIPLE SCLEROSIS JOURNAL | 2019年 / 25卷 / 03期
关键词：
D O I：
暂无
中图分类号：
R74 [神经病学与精神病学];
学科分类号：
摘要：
P-70
引用
收藏
页码：471 / 472
页数：2
相关论文
共 50 条
  • [41] Intrathecal triamcinolon therapy in advanced multiple sclerosis - long-term treatment in an outpatient MS clinic
    Kohler, J.
    Boelch, S.
    MULTIPLE SCLEROSIS, 2009, 15 (09): : S144 - S144
  • [42] Long-term experience with natalizumab as first-line treatment for highly active pediatric multiple sclerosis: a case report
    Daoudi, S.
    Lounis, M.
    MULTIPLE SCLEROSIS JOURNAL, 2017, 23 : 901 - 901
  • [43] Natalizumab Treatment of Relapsing Remitting Multiple Sclerosis Has No Long-Term Effects on the Proportion of Circulating Regulatory T Cells
    Tanasescu, Radu
    Frakich, Nanci
    Chou, I. -Jun
    Filippini, Perla
    Podda, Giulio
    Xin, Gao
    Muraleedharan, Ranjithmenon
    Jerca, Oltita
    Onion, David
    Constantinescu, Cris S.
    NEUROLOGY AND THERAPY, 2023, 12 (06) : 2041 - 2052
  • [44] Natalizumab Treatment of Relapsing Remitting Multiple Sclerosis Has No Long-Term Effects on the Proportion of Circulating Regulatory T Cells
    Radu Tanasescu
    Nanci Frakich
    I.-Jun Chou
    Perla Filippini
    Giulio Podda
    Gao Xin
    Ranjithmenon Muraleedharan
    Oltita Jerca
    David Onion
    Cris S. Constantinescu
    Neurology and Therapy, 2023, 12 : 2041 - 2052
  • [45] Natalizumab Treatment in Multiple Sclerosis
    Kurtuncu, Murat
    NOROPSIKIYATRI ARSIVI-ARCHIVES OF NEUROPSYCHIATRY, 2011, 48 : 56 - 60
  • [46] Natalizumab in the treatment of multiple sclerosis
    Horga, A.
    Horga de la Parte, J. F.
    REVISTA DE NEUROLOGIA, 2007, 45 (05) : 293 - 303
  • [47] Natalizumab treatment for multiple sclerosis
    Brito Ferreira, Maria Lucia
    ARQUIVOS DE NEURO-PSIQUIATRIA, 2014, 72 (12) : 911 - 912
  • [48] Effects of long-term natalizumab treatment on cell-bound natalizumab
    Hainke, U.
    Sehr, T.
    Marggraf, M.
    Thomas, K.
    Ziemssen, T.
    MULTIPLE SCLEROSIS JOURNAL, 2013, 19 (11) : 476 - 477
  • [49] Long-term effectiveness of natalizumab in secondary progressive multiple sclerosis: A propensity-matched study
    Chisari, Clara G.
    Aguglia, Umberto
    Amato, Maria Pia
    Bergamaschi, Roberto
    Bertolotto, Antonio
    Bonavita, Simona
    Morra, Vincenzo Brescia
    Cavalla, Paola
    Cocco, Eleonora
    Conte, Antonella
    Cottone, Salvatore
    De Luca, Giovanna
    Di Sapio, Alessia
    Filippi, Massimo
    Gallo, Antonio
    Gasperini, Claudio
    Granella, Franco
    Lus, Giacomo
    Maimone, Davide
    Maniscalco, Giorgia Teresa
    Marfia, Girolama
    Moiola, Lucia
    Paolicelli, Damiano
    Pesci, Ilaria
    Ragonese, Paolo
    Rovaris, Marco
    Salemi, Giuseppe
    Solaro, Claudio
    Totaro, Rocco
    Trojano, Maria
    Vianello, Marika
    Zaffaroni, Mauro
    Lepore, Vito
    Patti, Francesco
    NEUROTHERAPEUTICS, 2024, 21 (04)
  • [50] Alemtuzumab after natalizumab SWitch in evolving rapidly severe multiple sclerosis (ANSWERS MS): long-term UK & Ireland experience.
    Gallagher, P.
    McGuigan, C.
    Nicholas, R.
    Hobart, J.
    Ford, H.
    Petheram, K.
    Sharrack, B.
    Robertson, N.
    Mazibrada, G.
    Scolding, N.
    Wilson, M.
    Pearson, O.
    Jones, J.
    Overell, J.
    MULTIPLE SCLEROSIS JOURNAL, 2018, 24 : 99 - 100
12345